New Zealand Venture Investment Fund (NZVIF) is a venture capital firm that specializes in investing in the technology, media, and communication sectors. The firm focuses on providing start-up and growth capital to New Zealand-based tech companies. NZVIF typically participates in various investment rounds, including pre-seed, seed, Series A, and Series B, often collaborating with venture capital funds and angel investors to support early-stage ventures.

Notable portfolio companies include Dotterel, MiniMonos, Pathway Therapeutics, and Proacta, with investments ranging from $550,000 to $35 million. NZVIF's investment philosophy centers on fostering innovation and growth within New Zealand's tech ecosystem. The firm offers unique value-add services by leveraging its extensive network and expertise to help portfolio companies scale effectively. Key decision-makers at NZVIF are seasoned professionals with deep industry experience, ensuring strategic guidance and support for their investments.